Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography

Alzheimer’s disease (AD) is characterized by formation of amyloid plaques and neurofibrillary tangles in the brain, which can be mimicked by transgenic mouse models. Here, we report on the characterization of amyloid load in the brains of two transgenic amyloidosis models using positron emission tom...

Full description

Bibliographic Details
Main Authors: Antje Willuweit, Michael Schöneck, Sarah Schemmert, Philipp Lohmann, Saskia Bremen, Dominik Honold, Nicole Burda, Nan Jiang, Simone Beer, Johannes Ermert, Dieter Willbold, N. Jon Shah, Karl-Josef Langen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2021.699926/full
id doaj-51186c5f2d9b4530b8dde522890f16fe
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Antje Willuweit
Michael Schöneck
Sarah Schemmert
Philipp Lohmann
Philipp Lohmann
Saskia Bremen
Dominik Honold
Nicole Burda
Nan Jiang
Simone Beer
Johannes Ermert
Dieter Willbold
Dieter Willbold
N. Jon Shah
N. Jon Shah
N. Jon Shah
Karl-Josef Langen
Karl-Josef Langen
spellingShingle Antje Willuweit
Michael Schöneck
Sarah Schemmert
Philipp Lohmann
Philipp Lohmann
Saskia Bremen
Dominik Honold
Nicole Burda
Nan Jiang
Simone Beer
Johannes Ermert
Dieter Willbold
Dieter Willbold
N. Jon Shah
N. Jon Shah
N. Jon Shah
Karl-Josef Langen
Karl-Josef Langen
Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
Frontiers in Neuroscience
Alzheimer’s disease
small animal imaging
florbetaben
amyloid imaging
plaque burden
amyloidosis mouse model
author_facet Antje Willuweit
Michael Schöneck
Sarah Schemmert
Philipp Lohmann
Philipp Lohmann
Saskia Bremen
Dominik Honold
Nicole Burda
Nan Jiang
Simone Beer
Johannes Ermert
Dieter Willbold
Dieter Willbold
N. Jon Shah
N. Jon Shah
N. Jon Shah
Karl-Josef Langen
Karl-Josef Langen
author_sort Antje Willuweit
title Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
title_short Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
title_full Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
title_fullStr Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
title_full_unstemmed Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
title_sort comparison of the amyloid load in the brains of two transgenic alzheimer’s disease mouse models quantified by florbetaben positron emission tomography
publisher Frontiers Media S.A.
series Frontiers in Neuroscience
issn 1662-453X
publishDate 2021-10-01
description Alzheimer’s disease (AD) is characterized by formation of amyloid plaques and neurofibrillary tangles in the brain, which can be mimicked by transgenic mouse models. Here, we report on the characterization of amyloid load in the brains of two transgenic amyloidosis models using positron emission tomography (PET) with florbetaben (FBB), an 18F-labeled amyloid PET tracer routinely used in AD patients. Young, middle-aged, and old homozygous APP/PS1 mice (ARTE10), old hemizygous APPswe/PS1ΔE9, and old wild-type control mice were subjected to FBB PET using a small animal PET/computed tomography scanner. After PET, brains were excised, and ex vivo autoradiography was performed. Plaque pathology was verified on brain sections with histological methods. Amyloid plaque load increased progressively with age in the cortex and hippocampus of ARTE10 mice, which could be detected with both in vivo FBB PET and ex vivo autoradiography. FBB retention showed significant differences to wild-type controls already at 9 months of age by both in vivo and ex vivo analyses. An excellent correlation between data derived from PET and autoradiography could be obtained (rPearson = 0.947, p < 0.0001). Although amyloid load detected by FBB in the brains of old APPswe/PS1ΔE9 mice was as low as values obtained with young ARTE10 mice, statistically significant discrimination to wild-type animals was reached (p < 0.01). In comparison to amyloid burden quantified by histological analysis, FBB retention correlated best with total plaque load and number of congophilic plaques in the brains of both mouse models. In conclusion, the homozygous ARTE10 mouse model showed superior properties over APPswe/PS1ΔE9 mice for FBB small animal amyloid PET imaging. The absolute amount of congophilic dense-cored plaques seems to be the decisive factor for feasibility of amyloidosis models for amyloid PET analysis.
topic Alzheimer’s disease
small animal imaging
florbetaben
amyloid imaging
plaque burden
amyloidosis mouse model
url https://www.frontiersin.org/articles/10.3389/fnins.2021.699926/full
work_keys_str_mv AT antjewilluweit comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT michaelschoneck comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT sarahschemmert comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT philipplohmann comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT philipplohmann comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT saskiabremen comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT dominikhonold comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT nicoleburda comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT nanjiang comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT simonebeer comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT johannesermert comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT dieterwillbold comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT dieterwillbold comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT njonshah comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT njonshah comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT njonshah comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT karljoseflangen comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT karljoseflangen comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
_version_ 1716844349157801984
spelling doaj-51186c5f2d9b4530b8dde522890f16fe2021-10-04T05:20:44ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2021-10-011510.3389/fnins.2021.699926699926Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission TomographyAntje Willuweit0Michael Schöneck1Sarah Schemmert2Philipp Lohmann3Philipp Lohmann4Saskia Bremen5Dominik Honold6Nicole Burda7Nan Jiang8Simone Beer9Johannes Ermert10Dieter Willbold11Dieter Willbold12N. Jon Shah13N. Jon Shah14N. Jon Shah15Karl-Josef Langen16Karl-Josef Langen17Institute of Neuroscience and Medicine (INM-2, INM-4, INM-5, and INM-11), Forschungszentrum Jülich, Jülich, GermanyInstitute of Neuroscience and Medicine (INM-2, INM-4, INM-5, and INM-11), Forschungszentrum Jülich, Jülich, GermanyInstitute of Biological Information Processing, Structural Biochemistry, Forschungszentrum Jülich, Jülich, GermanyInstitute of Neuroscience and Medicine (INM-2, INM-4, INM-5, and INM-11), Forschungszentrum Jülich, Jülich, GermanyDepartment of Stereotaxy and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, GermanyInstitute of Neuroscience and Medicine (INM-2, INM-4, INM-5, and INM-11), Forschungszentrum Jülich, Jülich, GermanyInstitute of Biological Information Processing, Structural Biochemistry, Forschungszentrum Jülich, Jülich, GermanyInstitute of Neuroscience and Medicine (INM-2, INM-4, INM-5, and INM-11), Forschungszentrum Jülich, Jülich, GermanyInstitute of Biological Information Processing, Structural Biochemistry, Forschungszentrum Jülich, Jülich, GermanyInstitute of Neuroscience and Medicine (INM-2, INM-4, INM-5, and INM-11), Forschungszentrum Jülich, Jülich, GermanyInstitute of Neuroscience and Medicine (INM-2, INM-4, INM-5, and INM-11), Forschungszentrum Jülich, Jülich, GermanyInstitute of Biological Information Processing, Structural Biochemistry, Forschungszentrum Jülich, Jülich, GermanyInstitut für Physikalische Biologie, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, GermanyInstitute of Neuroscience and Medicine (INM-2, INM-4, INM-5, and INM-11), Forschungszentrum Jülich, Jülich, GermanyJARA-Brain-Translational Medicine, Aachen, GermanyDepartment of Neurology, RWTH Aachen University, Aachen, GermanyInstitute of Neuroscience and Medicine (INM-2, INM-4, INM-5, and INM-11), Forschungszentrum Jülich, Jülich, GermanyDepartment of Nuclear Medicine, RWTH Aachen University, Aachen, GermanyAlzheimer’s disease (AD) is characterized by formation of amyloid plaques and neurofibrillary tangles in the brain, which can be mimicked by transgenic mouse models. Here, we report on the characterization of amyloid load in the brains of two transgenic amyloidosis models using positron emission tomography (PET) with florbetaben (FBB), an 18F-labeled amyloid PET tracer routinely used in AD patients. Young, middle-aged, and old homozygous APP/PS1 mice (ARTE10), old hemizygous APPswe/PS1ΔE9, and old wild-type control mice were subjected to FBB PET using a small animal PET/computed tomography scanner. After PET, brains were excised, and ex vivo autoradiography was performed. Plaque pathology was verified on brain sections with histological methods. Amyloid plaque load increased progressively with age in the cortex and hippocampus of ARTE10 mice, which could be detected with both in vivo FBB PET and ex vivo autoradiography. FBB retention showed significant differences to wild-type controls already at 9 months of age by both in vivo and ex vivo analyses. An excellent correlation between data derived from PET and autoradiography could be obtained (rPearson = 0.947, p < 0.0001). Although amyloid load detected by FBB in the brains of old APPswe/PS1ΔE9 mice was as low as values obtained with young ARTE10 mice, statistically significant discrimination to wild-type animals was reached (p < 0.01). In comparison to amyloid burden quantified by histological analysis, FBB retention correlated best with total plaque load and number of congophilic plaques in the brains of both mouse models. In conclusion, the homozygous ARTE10 mouse model showed superior properties over APPswe/PS1ΔE9 mice for FBB small animal amyloid PET imaging. The absolute amount of congophilic dense-cored plaques seems to be the decisive factor for feasibility of amyloidosis models for amyloid PET analysis.https://www.frontiersin.org/articles/10.3389/fnins.2021.699926/fullAlzheimer’s diseasesmall animal imagingflorbetabenamyloid imagingplaque burdenamyloidosis mouse model